Sudarshan Chemical Industries Limited — Important, 26-07-2025: Disclosure of material issue

**Sudarshan Chemical Industries Ltd. (SUDCHEM)** FY25 consolidated results show robust revenue growth but a dip in net profit due to strategic shifts & acquisition costs.

**Financial Snapshot:**

* **FY25 Revenue:** Surged 31.7% YoY to ₹3,345.57 Cr (FY24: ₹2,538.78 Cr). Q4 FY25 revenue also strong at ₹1,349.44 Cr (Q4 FY24: ₹764.24 Cr).

* **FY25 Profit (before exceptional items & tax):** Up 30.5% YoY to ₹202.80 Cr (FY24: ₹155.43 Cr).

* **Net Profit (attributable to owners):** FY25 profit dropped to ₹99.17 Cr (FY24: ₹470.53 Cr). This is mainly due to the absence of last year's land sale gain (₹315.10 Cr) and inclusion of significant acquisition-related exceptional costs (₹103.63 Cr) this year.

* **EPS (before exceptional items):** FY25 EPS improved to ₹22.5 (FY24: ₹16.0).

* **Debt-Equity Ratio:** Increased to 0.95 (FY24: 0.38), reflecting acquisition funding.

* **Cash & Equivalents:** Spiked to ₹1,104.33 Cr from ₹47.24 Cr.

**The Big Story: Heubach Acquisition**

* **Issue:** Sudarshan Europe B.V. (SEBV), a wholly-owned subsidiary, completed the acquisition of Heubach Group's global pigment business operations in March 2025 for approx. ₹1,389.90 Cr (€151.9 million).

* **Impact:**

* The acquisition-related transaction and incidental costs of ₹103.63 Cr were recognized as exceptional expenses in FY25, hitting net profit.

* A significant "bargain purchase gain" of ₹1,243.85 Cr was recorded, reflecting the fair value of acquired assets exceeding the purchase consideration, boosting other comprehensive income.

* Consolidated financials now include Heubach from March 3, 2025, making direct comparison with previous periods difficult but indicating a much larger scale.

* The deal led to higher borrowings & increased the debt-equity ratio.

* **Company Response:** The acquisition was funded through a combination of external funds raised via a preferential allotment (₹195.00 Cr) and a Qualified Institutional Placement (QIP) (₹799.99 Cr) by the company, along with SEBV's own borrowings. This strategic move aims to significantly expand SUDCHEM's global footprint in pigments.

**Other Noteworthy Issue: HCIL Asset Transfer**

* **Issue:** Heubach Colorants India Limited (a subsidiary acquired in the Heubach deal) has an ongoing matter from 2019 concerning unauthorized transfer of certain assets to a related party. The resolution, including any financial impact, is still pending.

* **Company Response:** HCIL has engaged independent agencies for fact-finding and is exploring legal options to address this historical issue. Investors should monitor for future updates.

**Other Key Updates:**

* **Capital Structure:** The company increased its Authorised Share Capital. It also issued warrants to a promoter and completed preferential allotment & QIP to raise over ₹995 Cr for the acquisition and general corporate purposes.

* **Dividend:** The Board has put forward a dividend of ₹4.5 per share (225%) for FY25, subject to shareholder approval.

* **Leadership:** Mr. Rajesh Balkrishna Rathi is now Chairman of the Board, in addition to his role as Managing Director, following Mr. Pradeep Ramwilas Rathi's resignation.

* **Corporate Guarantee:** A corporate guarantee up to EURO 25 Million was approved for subsidiary hedging transactions.

**Investor Takeaway:** SUDCHEM is in a transformative phase post-Heubach acquisition, leading to significant balance sheet expansion and one-time costs impacting FY25 net profit. While operational performance (pre-exceptional) looks healthy, the full integration and impact of the acquisition, along with the resolution of the HCIL asset issue, will be key to watch.